SlowBull
The market, slowly. THURSDAY, 24 SEPTEMBER 2026
← All news
Markets

Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?

1 source ·1 article ·Sep 23, 08:15 UTC Global Partners ELI LILLY

Eli Lilly leads Novo Nordisk in GLP-1 market share and analyst sentiment, while Novo pins hopes on its CagriSema catalyst and pipeline to offset patent-cliff pressure and lawsuits.

Covered by 1 outlet

Marketbeat 1

All coverage · 1 article

MarketBeat ·Sep 23, 08:15 UTC

Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?

Eli Lilly leads Novo Nordisk in GLP-1 market share and analyst sentiment, while Novo pins hopes on its CagriSema catalyst and pipeline to offset patent-cliff pressure and lawsuits.